Boehringer Ingelheim Animal Health launches the first vaccine combination to protect pigs in Canada against two devastating diseases in one shot 

Burlington, Canada, June 15, 2023 – Boehringer Ingelheim Animal Health Canada Inc. has launched a vaccine combination that delivers protection against two of the most devastating and economically damaging swine diseases in one shot.

FLEX CircoPRRS^® protects pigs against porcine circovirus 2 (PCV2) and porcine reproductive and respiratory syndrome (PRRSv). These diseases can hinder performance and impair the immune system making pigs more susceptible to other diseases. Because of proprietary DiaTEC purification, combining the Boehringer Ingelheim PCV2 and PRRS vaccines (Ingelvac CircoFLEX^® and Ingelvac^®PRRS MLV) does not negatively impact PRRSv viability or the efficacy of either vaccine.

Dr. Martin Lafrenière, Technical Service Veterinarian with the Boehringer Ingelheim Animal Health Canada Livestock team, said the vaccine combination protects pigs and it is also beneficial for producers.

“This innovative vaccine combination provides producers with the convenience of a one-shot protocol that does not compromise the efficacy of the PRRS vaccine,” said Dr. Lafrenière. “By administering two vaccines in one shot, producers are protecting their herds against two devastating diseases while reducing stress on the pigs, saving time and reducing material costs.”

FLEX CircoPRRS^® is part of the FLEX vaccine portfolio which provides veterinarians and producers the ability to select the right vaccine that best fits their farm and disease management program. “We are pleased to provide this innovative vaccine combination to producers and veterinarians,” said Derek Groff, Business Unit Director, Livestock for Boehringer Ingelheim Animal Health Canada. “It will help keep pigs  healthy, support their well-being by reducing stress and help producers be more efficient by reducing the number of injections given. We know that when animals are healthy, people are healthier too.” 

When purchasing FLEX CircoPRRS^®, customers receive a bundle containing one 50-dose bottle of Ingelvac® PRRS MLV vaccine, along with one 50-dose bottle of Ingelvac CircoFLEX^®.

                                                                                                    - 30 -

Boehringer Ingelheim Animal Health Business Unit 

Boehringer Ingelheim Animal Health is working on first-in-class innovation for the prediction, prevention, and treatment of diseases in animals. For veterinarians, pet owners, farmers, and governments in more than 150 countries, we offer a large and innovative portfolio of products and services to improve the health and well-being of companion animals and livestock. As a global leader in the animal health industry and as part of family-owned Boehringer Ingelheim, we take a long-term perspective. The lives of animals and humans are interconnected in deep and complex ways. We know that when animals are healthy, humans are healthier too. By using the synergies between our Animal Health and Human Pharma businesses and by delivering value through innovation, we enhance the health and well- being of both. For more information visit www.boehringer-ingelheim.com/animal-health.

Boehringer Ingelheim Canada 

Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term, sustainable perspective. More than 53,000 employees serve over 130 markets in the two business units Human Pharma and Animal Health. The Canadian headquarters of Boehringer Ingelheim was established in 1972 in Montreal, Quebec and is now located in Burlington, Ontario. Boehringer Ingelheim employs approximately 500 people across Canada. Learn more at www.boehringer-ingelheim.ca.

FLEX CircoPRRS ^®, Ingelvac CircoFLEX^®  and Ingelvac ^®  PRRS MLV are registered trademarks of Boehringer Ingelheim Vetmedica GmbH, used under license.